arrow
Back
J

Jacek Jassem

medical university of gdansk

88H-index
1.0KPaper Count
5.7WCitation Count
Published Papers 206
Publication Date
First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial
err2026-06-08
err0
errOAAI
errPeter Schmid; Seock-Ah Im; Zbigniew Nowecki; Piotr J. Wysocki; Jacek Jassem; Kyung Hae Jung; Simon Lord; Jon Armstrong; Ross Stewart; Petra Vuković; Neelima Denduluri; Yeon Hee Park
errShare
errSave
Advancing Systemic Treatment beyond First Line for Advanced Hepatocellular Carcinoma
err2026-05-22
err0
errOAAI
errPiotr T. Wysocki; Paulina Chmiel; Jacek Jassem; Leszek Kraj
errShare
errSave
errShare
errSave
Genetic composition and evolutionary trajectories of brain metastasis in non-small-cell lung cancer
err2025-11-14
err0
PREAI
errMarcin Nicoś; Natalia Galant; Anna Kowalczyk; Rafał Pęksa; Bożena Jarosz; Monika Żuk; Bartosz Wasąg; Renata Duchnowska; Paweł Krawczyk; Jacek Jassem; Nicola Crosetto
errShare
errSave
Palbociclib with adjuvant endocrine therapy in early breast cancer: five-year follow up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)
err2025-10-17
err0
errOAAI
errE.L. Mayer; D. Hlauschek; M. Gnant; P.J. O'Brien; M. Bellet-Ezquerra; M.P. Goetz; M. Ruiz-Borrego; A. Chan; K. Clifton; D. Egle; D. Lake; P. Cabrera; T. Mamounas; G. Pristauz-Telsnigg; Z. Dayao; M. Gil Gil; D. Cameron; T. Traina; P.G. Morris; D. Sabanathan; G. Rinnerthaler; J. Meisel; A. Prat; A.C. Wolff; L-M. Tseng; C. Isaacs; C.F. Singer; G. Rubovszky; T. Foukakis; J. Jassem; E.P. Winer; M. Vetter; J. Federmann; O. Metzger; C. Schurmans; E. Gauthier; D.R. Lu; C. Fesl; A. Dueck; A. DeMichele
errShare
errSave
TTF-1 and p40 co-expression defines a distinct subtype of non-small cell lung cancer with frequent TP53 mutations and FGFR pathway dysregulation
err2025-09-30
err0
PREAI
errBraun, Marcin; Solek, Julia; Stepie, Grzegorz Jan; Maslowska, Aleksandra Izabela; Kamecki, Mateusz; Antosik, Paulina; Jassem, Jacek; Tomasik, Bartlomiej; Kordek, Radzislaw
errShare
errSave
Digital Versus Manual PD-L1 Scoring in Advanced Non-Small Cell Lung Cancer From the IMpower110 and IMpower150 Trials
err2025-08-05
err0
PREAI
errRoy S. Herbst; Hen Prizant; Daniel Ruderman; Jake Conway; John Shamshoian; Hartmut Koeppen; Wei Zou; Filippo de Marinis; Giuseppe Giaccone; Jacek Jassem; David R. Spigel; Mark A. Socinski; Martin Reck; Luciana Molinero; Marcus Ballinger; David Shames; Michael Griffin; Limin Yu; Nishant Agrawal; Andrew Beck; Ilan Wapinski; Stephanie Hennek; Jennifer Giltnane; Minu K. Srivastava
errShare
errSave
Clinical features and prognostic biomarkers in patients with SMARCA4-mutated non-small cell lung cancer
err2024-08-01
err1
errOAAI
errLong, Jinyu; Chen, Ying; Luo, Xingguang; Rao, Ruiying; Wang, Chenxi; Guo, Yuxin; Xu, Jinhe; Lin, Ping; Song, Yingfang; Qu, Lijuan; Liu, Qinghong; Lu, Jun; Zhou, Chengzhi; Song, Zhengbo; Lin, Xiandong; Adachi, Hiroyuki; Jassem, Jacek; Hamaji, Masatsugu; Yu, Zongyang
errShare
errSave
Targeting BTLA with the peptide inhibitor HVEM(14-39) - A new way to restore the activity of T cells in melanoma
err2024-06-01
err0
errOAAI
errWojciechowicz, Karolina; Kuncewicz, Katarzyna; Rutkowski, Jacek; Jassem, Jacek; Rodziewicz-Motowidlo, Sylwia; Wardowska, Anna; Spodzieja, Marta
errShare
errSave
The effect of gD-derived peptides on T cell immune response mediated by BTLA-HVEM protein complex in melanoma patients
err2024-05-21
err0
errOAAI
errWojciechowicz, Karolina; Kuncewicz, Katarzyna; Rutkowski, Jacek; Jassem, Jacek; Wardowska, Anna; Spodzieja, Marta
errShare
errSave
Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy: interim analysis of the ALEXANDRA/IMpassion030 phase 3 trial
err2024-05-02
err3
PREAI
errIgnatiadis, Michail; Bailey, Andrew; McArthur, Heather; El-Abed, Sarra; de Azambuja, Evandro; Metzger, Otto; Chui, Steve; Dieterich, Max; Perretti, Thomas; Steger, Guenther; Jassem, Jacek; Lee, Soo Chin; Higgins, Michaela; Zarba, Jose; Schmidt, Marcus; Gomez, Henry; Guerrero-Zotano, Angel; Moscetti, Luca; Chiu, Joanne Win Yang; DuFrane, Carter; Honvault, Vanessa; Altarcheh, Rosa; Molinero, Luciana; Ellingson, Andrew; Munzone, Elisabetta; Ben-Baruch, Noa Efrat; Bajetta, Emilio; Ohno, Shinji; Im, Seock-Ah; Werutsky, Gustavo; Gal-Yam, Einav; Gonzalez-Farre, Xavier; Tseng, Ling-Ming; Jacot, William; Gluz, Oleg; Shao, Zhimin; Shparyk, Yaroslav; Sinielnikov, Ivan; Anastasia, Zimina; Vasiliev, Aleksandr; Shearer-Kang, Esther; Winer, Eric; Martins-Branco, Diogo; Fielding, Shona; Cameron, David; Viale, Giuseppe; Saji, Shigehira; Gelber, Richard; Piccart, Martine
errShare
errSave
Stroke heralding granulomatosis with polyangiitis
err2024-02-23
err0
errOAAI
errJanowiak, Piotr; Gorzewska, Agnieszka; Szade, Jolanta; Bednarska, Magdalena; Jassem, Jacek; Jassem, Ewa
errShare
errSave
Deep Learning-Based, Multiclass Approach to Cancer Classification on Liquid Biopsy Data
err2024-01-01
err5
errOAAI
errJopek, Maksym A.; Pastuszak, Krzysztof; Cygert, Sebastian; Best, Myron G.; Wurdinger, Thomas; Jassem, Jacek; Zaczek, Anna J.; Supernat, Anna
errShare
errSave
Radiotherapy-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with laryngeal cancer indicate poor prognosis
err2023-10-10
err3
errOAAI
errCichowska-Cwalinska, Natalia; Bienkowski, Michal; Popeda, Marta; Drozka, Magdalena; Rutkowski, Jacek; Jassem, Jacek; Zaucha, Renata
errShare
errSave
errShare
errSave
Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients
err2023-07-21
err1
errOAAI
errCytawa, Wojciech; Hendel, Robin; Tomasik, Bartlomiej; Weinzierl, Franz-Xaver; Bley, Thorsten; Jassem, Jacek; Schirbel, Andreas; Buck, Andreas K.; Bundschuh, Ralph A.; Hartrampf, Philipp E.; Werner, Rudolf A.; Lapa, Constantin
errShare
errSave
Plain language summary of the updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancer
err2023-06-12
err0
errOAAI
errSolomon, Benjamin J.; Bauer, Todd M.; Mok, Tony S. K.; Liu, Geoffrey; Mazieres, Julien; de Marinis, Filippo; Goto, Yasushi; Kim, Dong-Wan; Wu, Yi-Long; Jassem, Jacek; Lopez, Froylan Lopez; Soo, Ross A.; Shaw, Alice T.; Polli, Anna; Messina, Rossella; Iadeluca, Laura; Toffalorio, Francesca; Felip, Enriqueta
errShare
errSave
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
err2023-04-01
err111
PREAI
errSolomon, Benjamin J.; Bauer, Todd M.; Mok, Tony S. K.; Liu, Geoffrey; Mazieres, Julien; de Marinis, Filippo; Goto, Yasushi; Kim, Dong-Wan; Wu, Yi-Long; Jassem, Jacek; Lopez, Froylan Lopez; Soo, Ross A.; Shaw, Alice T.; Polli, Anna; Messina, Rossella; Iadeluca, Laura; Toffalorio, Francesca; Felip, Enriqueta
errShare
errSave